Modalis Therapeutics Corporation (JP:4883) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Modalis Therapeutics Corporation announces a new executive appointment with Yosuke Nakashima stepping up as VP of Operations and Business Development, after serving as Director of Business Development and US Site Controller.
For further insights into JP:4883 stock, check out TipRanks’ Stock Analysis page.